ArticleOncotarget2016

Icariside II overcomes TRAIL resistance of melanoma cells through ROS-mediated downregulation of STAT3/cFLIP signaling.

Juan Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.